Galmed Pharmaceuticals Ltd. (GLMD)

Galmed Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	9.72	2.86	2.02	2.88	6.95	15.93
Short-Term Investments	7.42	9.78	11.77	31.93	43.94	59.56
Cash & Short-Term Investments	17.14	12.64	13.79	34.82	50.89	75.49
Cash Growth	28.75%	-8.29%	-60.41%	-31.58%	-32.59%	-16.30%
Other Receivables	0.43	0.17	0.16	0.08	0.07	0.23
Receivables	0.43	0.17	0.16	0.08	0.07	0.23
Prepaid Expenses	-	0.32	0.67	1.05	0.75	0.6
Restricted Cash	0.12	0.12	0.11	0.11	0.11	0.11
Total Current Assets	17.69	13.24	14.72	36.05	51.81	76.43
Property, Plant & Equipment	-	0.13	0.34	0.55	0.57	0.71
Long-Term Investments	3.27	3.27	1.5	-	-	-
Total Assets	20.95	16.63	16.56	36.61	52.38	77.14
Accounts Payable	1.34	1.88	2.56	4.87	7.05	6
Current Portion of Leases	-	0.04	0.17	0.21	0.2	-
Other Current Liabilities	1.17	0.83	0.36	0.8	0.76	0.94
Total Current Liabilities	2.51	2.75	3.09	5.88	8.01	6.93
Long-Term Leases	-	-	0.04	0.23	0.22	0.35
Total Liabilities	2.51	2.75	3.14	6.11	8.23	7.29
Common Stock	0.67	0.21	0.07	0.07	0.06	0.06
Additional Paid-In Capital	215.37	207.08	200.14	198.77	179.53	176.7
Retained Earnings	-197.26	-192.95	-186.04	-168.17	-135.71	-106.94
Comprehensive Income & Other	-0.34	-0.45	-0.75	-0.17	0.27	0.04
Shareholders' Equity	18.44	13.88	13.42	30.5	44.15	69.85
Total Liabilities & Equity	20.95	16.63	16.56	36.61	52.38	77.14
Total Debt	-	0.04	0.22	0.44	0.42	0.35
Net Cash (Debt)	17.14	12.6	13.57	34.38	50.47	75.14
Net Cash Growth	28.75%	-7.13%	-60.53%	-31.88%	-32.84%	-16.69%
Net Cash Per Share	30.67	54.60	97.14	251.58	426.87	640.56
Filing Date Shares Outstanding	1.51	0.5	0.14	0.14	0.14	0.12
Total Common Shares Outstanding	1.51	0.42	0.14	0.14	0.12	0.12
Working Capital	15.17	10.49	11.63	30.18	43.8	69.5
Book Value Per Share	12.23	33.01	95.87	218.80	372.67	594.79
Tangible Book Value	18.44	13.88	13.42	30.5	44.15	69.85
Tangible Book Value Per Share	12.23	33.01	95.87	218.80	372.67	594.79
Machinery	-	0.79	0.79	0.79	0.79	0.79
Leasehold Improvements	-	0.24	0.24	0.23	0.22	0.2

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q